Education
About Us
Working with TipRanks
Follow Us
Keith Katkin Insider Profile
4 Followers
Keith Katkin, President & CEO, Director at Avanir Pharmaceuticals, holds 86.43K shares in Emergent Biosolutions (Ticker: EBS), holds 100.00K shares in Syndax Pharmaceuticals (Ticker: SNDX), holds 25.00K shares in Rigel (Ticker: RIGL).
Keith Katkin Avanir Pharmaceuticals (AVNR)President & CEO, Director
Avanir Pharmaceuticals (AVNR)
President & CEO, Director
Not Ranked
Keith Katkin has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Keith Katkin holds in companies
Most Profitable Insider Trade
The most profitable trade made by Keith Katkin
Keith Katkin's Trading History
Avanir Pharmaceuticals
Dec 17, 2014
―
Uninformative Sell
4.71M
―
Syndax Pharmaceuticals
May 19, 2025
Director
Informative Buy
91.10K
$963.00K
Eledon Pharmaceuticals
May 11, 2017
Director
Uninformative Buy
―
$43.87K
Urovant Sciences
Jan 09, 2020
―
Uninformative Buy
―
$3.24M
Emergent Biosolutions
May 28, 2025
Director
Uninformative Sell
49.42K
$619.71K
Rigel
May 21, 2021
Director
Uninformative Buy
―
$504.25K
KalVista Pharmaceuticals
―
Director
―
$0.00
List of latest transactions for each holding click on a transaction to see Keith Katkin's performance on stock
You May Also Like
Keith Katkin insider profile FAQ
What is the percentage of profitable transactions made by Keith Katkin?
The percentage of profitable transactions made by Keith Katkin is ―.
What is the average return per transaction made by Keith Katkin?
The average return per transaction made by Keith Katkin is ―.
What stocks does Keith Katkin hold?
Keith Katkin holds: AVNR, SNDX, ELDN, UROV, EBS, RIGL, KALV stocks.
What was Keith Katkin’s latest transaction?
Keith Katkin latest transaction was an Uninformative Sell of $49.42K.
What was Keith Katkin's most profitable transaction?
Keith Katkin’s most profitable transaction was an Informative Buy of SNDX stock on May 19, 2025. The return on the trade was 1.70%.
What is Keith Katkin's role in Avanir Pharmaceuticals?
Keith Katkin's role in Avanir Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.